This product is an ASHP Learning Center activity.
Accreditation for Pharmacists
The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with Commendation.
This activity is intended for pharmacists implementing and providing pharmacist-initiated therapy services including point-of-care testing and diagnostic services for health conditions for which they are permitted by legislation and regulation.
Pharmacist-Initiated Therapy Microcredentials are self-guided online learning activities for pharmacists seeking to increase their knowledge and skill in providing pharmacist-initiated services for specific health conditions.
A learner will have completed the Pharmacist-Initiated Therapy Corebefore beginning the Continuous Glucose Monitoring Microcredential.
The Pharmacist-Initiated Therapy Core curriculum addresses the basic principles associated with establishing these services including an overview of services, interpreting scope of practice in legislation and regulatory guidance, implementation strategies, workflow development, marketing of services, basic physical assessment, reimbursement tactics, and quality improvement measures.
The Continuous Glucose Monitoring (CGM) Microcredential curriculum provides learners with a description of CGM devices currently available, selecting the most appropriate CGM device based on patient-specific factors, interpreting CGM data and utilizing them to guide diabetes treatment decisions, and strategies for overcoming barriers to CGM implementation.
Once a learner has completed the Pharmacist-Initiated Therapy Core and the Continuous Glucose Monitoring Microcredential educational curriculum, they will have the opportunity to complete the microcredential final exam. Once the learner successfully completes the microcredential final exam (minimum 80% passing rate; unlimited attempts permitted), they will be awarded the Pharmacist-Initiated Therapy Continuous Glucose Monitoring Microcredential.
Getting Started: Planning and Analysis
1.5 contact hours
- Identify the types of services that may be provided in pharmacist-initiated therapy.
- Describe the roles and responsibilities of a pharmacist to the patient and the healthcare team.
- Contrast the existing evidence for pharmacist-initiated therapies.
- Differentiate strategies used by states that have implemented pharmacist-initiated therapy programs.
- Interpret the scope of practice for pharmacist-initiated therapies in approved State and Federal legislation and regulations.
- Summarize how implementing programs for pharmacist-initiated therapies in pharmacies benefit public health needs of the local community.
- Identify physician, legislative, and public health partners or champions that can be resources for implementing new services for pharmacist-initiated therapies in pharmacies.
- Develop a plan to overcome common barriers to implementing services for pharmacist-initiated therapies.
1.5 contact hours
- Summarize preparations and considerations for drafting a workflow plan.
- Identify resources and tools needed to establish a pharmacist-initiated therapy service.
- Design workflows to optimize efficiency and avoid common pitfalls.
- Discuss best practices used to implement and enhance the workflow.
- List the elements of a marketing plan.
- Develop internal and external marketing strategies.
1.5 contact hours
- Describe the correct steps for measuring blood pressure based on recommendations from the American Heart Association
- Select the correct cuff size when measuring blood pressure in an adult
- Identify if a person has orthostatic hypotension
- Calculate a person's heart rate using the radial pulse and via cardiac auscultation
Reimbursement and Quality Improvement
1.5 contact hours
- Evaluate health care and organizational information along with current billing processes to maximize reimbursement for a pharmacist initiated therapy service.
- Identify billing mechanisms and billing codes that are appropriate to use for pharmacist-initiated therapy in various practice settings.
- Analyze processes to optimize reimbursement for pharmacist-initiated therapy.
- Describe elements needed for ensuring quality of pharmacist-initiated patient therapy.
- Summarize measures used for performance improvement, quality monitoring, and reporting of services related to pharmacist-initiated patient therapy.
- Design a systematic process for assessing the quality of services provided through pharmacist-initiated patient therapy.
Continuous Glucose Monitoring
2.5 contact hours
- Describe the process for obtaining third party coverage for continuous glucose monitoring (CGM) for people with diabetes.
- Explain the current procedural terminology (CPT) reimbursement codes related to CGM services and how to utilize them in practice.
Lorinda Anderson, PharmD, BCPS
Clinical Assistant Professor
Oregon State University College of Pharmacy
Inpatient Clinical Pharmacist
Samaritan Health Services
Magdi Awad, PharmD, MSA
Associate Professor of Pharmacy Practice
Northeast Ohio Medical University
Director of Pharmacy
AxessPointe Community Health Centers
Diana Isaacs, PharmD, BCACP, CDCES, BC-ADM, FADCES, FCCP
Endocrine Clinical Pharmacy Specialist/CGM Program Coordinator
Mary Ann Kliethermes, BSPharm, PharmD, FAPhA, FCIOM
Director of Medication Safety and Quality
Anna Legreid Dopp, PharmD, CPHQ
Senior Director, Clinical Guidelines & Quality Improvement
Eric Maroyka, PharmD, BCPS
Senior Director, ASHP Center on Pharmacy Practice Advancement
Kristin Watson, PharmD, BCCP
PGY2 Cardiology Pharmacy Residency Director
University of Maryland School of Pharmacy
Relevant Financial Relationship Disclosure
In accordance with our accreditor's Standards of Integrity and Independence in Accredited Continuing Education, ASHP requires that all individuals in control of content disclose all financial relationships with ineligible companies. An individual has a relevant financial relationship if they have had a financial relationship with ineligible company in any dollar amount in the past 24 months and the educational content that the individual controls is related to the business lines or products of the ineligible company.
An ineligible company is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The presence or absence of relevant financial relationships will be disclosed to the activity audience.
- No one in control of the content of this activity has a relevant financial relationship (RFR) with an ineligible company.
As defined by the Standards of Integrity and Independence definition of ineligible company. All relevant financial relationships have been mitigated prior to the CPE activity.
Methods and CE Requirements
This online activity consists of a combined total of 5 learning modules. Pharmacists are eligible to receive a total of 8.5 hours of continuing education credit by completing all 5 modules within this program.
Participants must participate in the entire activity and complete the evaluation and all required components to claim continuing pharmacy education credit online at ASHP Learning Center. Follow the prompts to claim credit and view your statement of credit within 60 days of completing the activity.
Important Note – ACPE 60 Day Deadline:
Per ACPE requirements, CPE credit must be claimed within 60 days of being earned. To verify that you have completed the required steps and to ensure your credits have been reported to CPE Monitor, check your NABP eProfile account to validate that your credits were transferred successfully before the ACPE 60-day deadline. After the 60-day deadline, ASHP will no longer be able to award credit for this activity.
System Technical Requirements
System requirements courses and learning activities are delivered via your web browser and Acrobat PDF. Users should have a basic comfort level using a computer and navigating web sites. View the minimum technical and system requirements for learning activities.